Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset

Childhood Attention-deficit/hyperactivity disorder (C-ADHD) is a neurodevelopmental disorder, associated with an increased risk of subsequent schizophrenia. The objective of the present study was to determine the prevalence of C-ADHD in schizophrenia and the clinical and cognitive characteristics as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Schizophrenia research 2024-02, Vol.264, p.105-112
Hauptverfasser: Dondé, Clément, Coulon, Nathalie, Turbé, Hugo, Andre, Myrtille, Boyer, Laurent, Capdevielle, Delphine, Chereau, Isabelle, Dassing, Romane, Dorey, Jean-Michel, Dubertret, Caroline, Leignier, Sylvain, Llorca, Pierre-Michel, Misdrahi, David, Passerieux, Christine, Pignon, Baptiste, Rey, Romain, Schorr, Benoît, Schürhoff, Franck, Urbach, Mathieu, Fond, Guillaume, Mallet, Jasmina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 112
container_issue
container_start_page 105
container_title Schizophrenia research
container_volume 264
creator Dondé, Clément
Coulon, Nathalie
Turbé, Hugo
Andre, Myrtille
Boyer, Laurent
Capdevielle, Delphine
Chereau, Isabelle
Dassing, Romane
Dorey, Jean-Michel
Dubertret, Caroline
Leignier, Sylvain
Llorca, Pierre-Michel
Misdrahi, David
Passerieux, Christine
Pignon, Baptiste
Rey, Romain
Schorr, Benoît
Schürhoff, Franck
Urbach, Mathieu
Fond, Guillaume
Mallet, Jasmina
description Childhood Attention-deficit/hyperactivity disorder (C-ADHD) is a neurodevelopmental disorder, associated with an increased risk of subsequent schizophrenia. The objective of the present study was to determine the prevalence of C-ADHD in schizophrenia and the clinical and cognitive characteristics associated with C-ADHD history in schizophrenia. 569 subjects with schizophrenia (74 % men, mean age 30.8) were included in ten expert centers at a national level and tested with a comprehensive battery of clinician-rated, patient-reported scales and cognitive tests. C-ADHD was assessed with the WURS (Wender Utah Rating Scale) self-report questionnaire. Multivariate, correlation, and principal component analyses (PCA) were conducted. Thirty-nine subjects (N = 39, 6.9 %) were classified in the C-ADHD group. Compared to those without C-ADHD, subjects with C-ADHD were more frequently male, had lower education levels, more severe positive clinical symptoms, more subjective cognitive deficits complaints, and lower medication adherence with small to medium effect sizes. Two cognitive components emerged from the PCA, one component including perceptual reasoning and working memory, and another component including visuospatial search and graphomotor speed, cognitive inhibition/flexibility and central executive functioning. Both components were associated with lower performances in the C-ADHD group. C-ADHD is frequent in schizophrenia and associated with more severe positive symptoms and impaired cognitive performances compared to those without C-ADHD. This suggests that the pathophysiological mechanisms contributing to these disorders may lead to the worsening of the cognitive functioning in patients with both disorders. C-ADHD is a relevant clinical marker to discriminate subgroups of schizophrenia with different profiles for a precision-psychiatry approach.
doi_str_mv 10.1016/j.schres.2023.12.010
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04512686v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0920996423004486</els_id><sourcerecordid>2905514823</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-7f168662d7ae14b360557f59036b23d9f7632e07b2b29262d3e642afe3882b6f3</originalsourceid><addsrcrecordid>eNp9kUuP0zAUhSMEYjoD_wAhL2GRjB-Jk7BAqqp5IFVC4rFhYzn2DblVGhfbKSp_jT-HS4ZZsrJsfeec63uy7BWjBaNMXu-KYAYPoeCUi4LxgjL6JFuxqhY5r2j7NFvRltO8bWV5kV2GsKOUsorWz7ML0TDeiJKtst-bESc0eiR6ssS47xNGPAIxg_baRPAYIppAXE_C3O3AxEB-YhxICsdf7pAmmFAv4gFHOzhniY4Rpohuyi30aDBeD6cDnP3wiPFELAbnLfh35BOEeUyWvXd7Egcg-3RFk9QeDbldb27yz9-I8S6EPKTw5JlGtTrqAPFF9qzXY4CXD-dV9vX25svmPt9-vPuwWW9zI1oZ87pnspGS21oDKzshaVXVfdVSITsubNvXUnCgdcc73vLECZAl1z2IpuGd7MVV9nbxHfSoDh732p-U06ju11t1fqNlxXjKOLLEvlnYg3c_ZghR7TEYGEc9gZuD4m1KZ2XDRULLBf37PQ_9ozej6lyx2qmlYnWuWDGuUsVJ9vohYe72YB9F_zpNwPsFgLSTI4JPLgiTAYs-rVBZh_9P-ANkOL1V</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2905514823</pqid></control><display><type>article</type><title>Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset</title><source>Access via ScienceDirect (Elsevier)</source><creator>Dondé, Clément ; Coulon, Nathalie ; Turbé, Hugo ; Andre, Myrtille ; Boyer, Laurent ; Capdevielle, Delphine ; Chereau, Isabelle ; Dassing, Romane ; Dorey, Jean-Michel ; Dubertret, Caroline ; Leignier, Sylvain ; Llorca, Pierre-Michel ; Misdrahi, David ; Passerieux, Christine ; Pignon, Baptiste ; Rey, Romain ; Schorr, Benoît ; Schürhoff, Franck ; Urbach, Mathieu ; Fond, Guillaume ; Mallet, Jasmina</creator><creatorcontrib>Dondé, Clément ; Coulon, Nathalie ; Turbé, Hugo ; Andre, Myrtille ; Boyer, Laurent ; Capdevielle, Delphine ; Chereau, Isabelle ; Dassing, Romane ; Dorey, Jean-Michel ; Dubertret, Caroline ; Leignier, Sylvain ; Llorca, Pierre-Michel ; Misdrahi, David ; Passerieux, Christine ; Pignon, Baptiste ; Rey, Romain ; Schorr, Benoît ; Schürhoff, Franck ; Urbach, Mathieu ; Fond, Guillaume ; Mallet, Jasmina</creatorcontrib><description>Childhood Attention-deficit/hyperactivity disorder (C-ADHD) is a neurodevelopmental disorder, associated with an increased risk of subsequent schizophrenia. The objective of the present study was to determine the prevalence of C-ADHD in schizophrenia and the clinical and cognitive characteristics associated with C-ADHD history in schizophrenia. 569 subjects with schizophrenia (74 % men, mean age 30.8) were included in ten expert centers at a national level and tested with a comprehensive battery of clinician-rated, patient-reported scales and cognitive tests. C-ADHD was assessed with the WURS (Wender Utah Rating Scale) self-report questionnaire. Multivariate, correlation, and principal component analyses (PCA) were conducted. Thirty-nine subjects (N = 39, 6.9 %) were classified in the C-ADHD group. Compared to those without C-ADHD, subjects with C-ADHD were more frequently male, had lower education levels, more severe positive clinical symptoms, more subjective cognitive deficits complaints, and lower medication adherence with small to medium effect sizes. Two cognitive components emerged from the PCA, one component including perceptual reasoning and working memory, and another component including visuospatial search and graphomotor speed, cognitive inhibition/flexibility and central executive functioning. Both components were associated with lower performances in the C-ADHD group. C-ADHD is frequent in schizophrenia and associated with more severe positive symptoms and impaired cognitive performances compared to those without C-ADHD. This suggests that the pathophysiological mechanisms contributing to these disorders may lead to the worsening of the cognitive functioning in patients with both disorders. C-ADHD is a relevant clinical marker to discriminate subgroups of schizophrenia with different profiles for a precision-psychiatry approach.</description><identifier>ISSN: 0920-9964</identifier><identifier>EISSN: 1573-2509</identifier><identifier>DOI: 10.1016/j.schres.2023.12.010</identifier><identifier>PMID: 38128341</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>ADHD ; Attention deficit ; Healthcare system research ; Life Sciences ; Mental health ; Neurons and Cognition ; Psychiatry ; Schizophrenia, psychotic disorders</subject><ispartof>Schizophrenia research, 2024-02, Vol.264, p.105-112</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-7f168662d7ae14b360557f59036b23d9f7632e07b2b29262d3e642afe3882b6f3</citedby><cites>FETCH-LOGICAL-c396t-7f168662d7ae14b360557f59036b23d9f7632e07b2b29262d3e642afe3882b6f3</cites><orcidid>0000-0002-5121-8769 ; 0000-0002-7146-8554 ; 0000-0001-5050-1362 ; 0000-0001-7438-8990 ; 0000-0003-1146-3206 ; 0000-0003-4130-1590</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.schres.2023.12.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38128341$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04512686$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Dondé, Clément</creatorcontrib><creatorcontrib>Coulon, Nathalie</creatorcontrib><creatorcontrib>Turbé, Hugo</creatorcontrib><creatorcontrib>Andre, Myrtille</creatorcontrib><creatorcontrib>Boyer, Laurent</creatorcontrib><creatorcontrib>Capdevielle, Delphine</creatorcontrib><creatorcontrib>Chereau, Isabelle</creatorcontrib><creatorcontrib>Dassing, Romane</creatorcontrib><creatorcontrib>Dorey, Jean-Michel</creatorcontrib><creatorcontrib>Dubertret, Caroline</creatorcontrib><creatorcontrib>Leignier, Sylvain</creatorcontrib><creatorcontrib>Llorca, Pierre-Michel</creatorcontrib><creatorcontrib>Misdrahi, David</creatorcontrib><creatorcontrib>Passerieux, Christine</creatorcontrib><creatorcontrib>Pignon, Baptiste</creatorcontrib><creatorcontrib>Rey, Romain</creatorcontrib><creatorcontrib>Schorr, Benoît</creatorcontrib><creatorcontrib>Schürhoff, Franck</creatorcontrib><creatorcontrib>Urbach, Mathieu</creatorcontrib><creatorcontrib>Fond, Guillaume</creatorcontrib><creatorcontrib>Mallet, Jasmina</creatorcontrib><title>Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset</title><title>Schizophrenia research</title><addtitle>Schizophr Res</addtitle><description>Childhood Attention-deficit/hyperactivity disorder (C-ADHD) is a neurodevelopmental disorder, associated with an increased risk of subsequent schizophrenia. The objective of the present study was to determine the prevalence of C-ADHD in schizophrenia and the clinical and cognitive characteristics associated with C-ADHD history in schizophrenia. 569 subjects with schizophrenia (74 % men, mean age 30.8) were included in ten expert centers at a national level and tested with a comprehensive battery of clinician-rated, patient-reported scales and cognitive tests. C-ADHD was assessed with the WURS (Wender Utah Rating Scale) self-report questionnaire. Multivariate, correlation, and principal component analyses (PCA) were conducted. Thirty-nine subjects (N = 39, 6.9 %) were classified in the C-ADHD group. Compared to those without C-ADHD, subjects with C-ADHD were more frequently male, had lower education levels, more severe positive clinical symptoms, more subjective cognitive deficits complaints, and lower medication adherence with small to medium effect sizes. Two cognitive components emerged from the PCA, one component including perceptual reasoning and working memory, and another component including visuospatial search and graphomotor speed, cognitive inhibition/flexibility and central executive functioning. Both components were associated with lower performances in the C-ADHD group. C-ADHD is frequent in schizophrenia and associated with more severe positive symptoms and impaired cognitive performances compared to those without C-ADHD. This suggests that the pathophysiological mechanisms contributing to these disorders may lead to the worsening of the cognitive functioning in patients with both disorders. C-ADHD is a relevant clinical marker to discriminate subgroups of schizophrenia with different profiles for a precision-psychiatry approach.</description><subject>ADHD</subject><subject>Attention deficit</subject><subject>Healthcare system research</subject><subject>Life Sciences</subject><subject>Mental health</subject><subject>Neurons and Cognition</subject><subject>Psychiatry</subject><subject>Schizophrenia, psychotic disorders</subject><issn>0920-9964</issn><issn>1573-2509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kUuP0zAUhSMEYjoD_wAhL2GRjB-Jk7BAqqp5IFVC4rFhYzn2DblVGhfbKSp_jT-HS4ZZsrJsfeec63uy7BWjBaNMXu-KYAYPoeCUi4LxgjL6JFuxqhY5r2j7NFvRltO8bWV5kV2GsKOUsorWz7ML0TDeiJKtst-bESc0eiR6ssS47xNGPAIxg_baRPAYIppAXE_C3O3AxEB-YhxICsdf7pAmmFAv4gFHOzhniY4Rpohuyi30aDBeD6cDnP3wiPFELAbnLfh35BOEeUyWvXd7Egcg-3RFk9QeDbldb27yz9-I8S6EPKTw5JlGtTrqAPFF9qzXY4CXD-dV9vX25svmPt9-vPuwWW9zI1oZ87pnspGS21oDKzshaVXVfdVSITsubNvXUnCgdcc73vLECZAl1z2IpuGd7MVV9nbxHfSoDh732p-U06ju11t1fqNlxXjKOLLEvlnYg3c_ZghR7TEYGEc9gZuD4m1KZ2XDRULLBf37PQ_9ozej6lyx2qmlYnWuWDGuUsVJ9vohYe72YB9F_zpNwPsFgLSTI4JPLgiTAYs-rVBZh_9P-ANkOL1V</recordid><startdate>202402</startdate><enddate>202402</enddate><creator>Dondé, Clément</creator><creator>Coulon, Nathalie</creator><creator>Turbé, Hugo</creator><creator>Andre, Myrtille</creator><creator>Boyer, Laurent</creator><creator>Capdevielle, Delphine</creator><creator>Chereau, Isabelle</creator><creator>Dassing, Romane</creator><creator>Dorey, Jean-Michel</creator><creator>Dubertret, Caroline</creator><creator>Leignier, Sylvain</creator><creator>Llorca, Pierre-Michel</creator><creator>Misdrahi, David</creator><creator>Passerieux, Christine</creator><creator>Pignon, Baptiste</creator><creator>Rey, Romain</creator><creator>Schorr, Benoît</creator><creator>Schürhoff, Franck</creator><creator>Urbach, Mathieu</creator><creator>Fond, Guillaume</creator><creator>Mallet, Jasmina</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-5121-8769</orcidid><orcidid>https://orcid.org/0000-0002-7146-8554</orcidid><orcidid>https://orcid.org/0000-0001-5050-1362</orcidid><orcidid>https://orcid.org/0000-0001-7438-8990</orcidid><orcidid>https://orcid.org/0000-0003-1146-3206</orcidid><orcidid>https://orcid.org/0000-0003-4130-1590</orcidid></search><sort><creationdate>202402</creationdate><title>Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset</title><author>Dondé, Clément ; Coulon, Nathalie ; Turbé, Hugo ; Andre, Myrtille ; Boyer, Laurent ; Capdevielle, Delphine ; Chereau, Isabelle ; Dassing, Romane ; Dorey, Jean-Michel ; Dubertret, Caroline ; Leignier, Sylvain ; Llorca, Pierre-Michel ; Misdrahi, David ; Passerieux, Christine ; Pignon, Baptiste ; Rey, Romain ; Schorr, Benoît ; Schürhoff, Franck ; Urbach, Mathieu ; Fond, Guillaume ; Mallet, Jasmina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-7f168662d7ae14b360557f59036b23d9f7632e07b2b29262d3e642afe3882b6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ADHD</topic><topic>Attention deficit</topic><topic>Healthcare system research</topic><topic>Life Sciences</topic><topic>Mental health</topic><topic>Neurons and Cognition</topic><topic>Psychiatry</topic><topic>Schizophrenia, psychotic disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dondé, Clément</creatorcontrib><creatorcontrib>Coulon, Nathalie</creatorcontrib><creatorcontrib>Turbé, Hugo</creatorcontrib><creatorcontrib>Andre, Myrtille</creatorcontrib><creatorcontrib>Boyer, Laurent</creatorcontrib><creatorcontrib>Capdevielle, Delphine</creatorcontrib><creatorcontrib>Chereau, Isabelle</creatorcontrib><creatorcontrib>Dassing, Romane</creatorcontrib><creatorcontrib>Dorey, Jean-Michel</creatorcontrib><creatorcontrib>Dubertret, Caroline</creatorcontrib><creatorcontrib>Leignier, Sylvain</creatorcontrib><creatorcontrib>Llorca, Pierre-Michel</creatorcontrib><creatorcontrib>Misdrahi, David</creatorcontrib><creatorcontrib>Passerieux, Christine</creatorcontrib><creatorcontrib>Pignon, Baptiste</creatorcontrib><creatorcontrib>Rey, Romain</creatorcontrib><creatorcontrib>Schorr, Benoît</creatorcontrib><creatorcontrib>Schürhoff, Franck</creatorcontrib><creatorcontrib>Urbach, Mathieu</creatorcontrib><creatorcontrib>Fond, Guillaume</creatorcontrib><creatorcontrib>Mallet, Jasmina</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Schizophrenia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dondé, Clément</au><au>Coulon, Nathalie</au><au>Turbé, Hugo</au><au>Andre, Myrtille</au><au>Boyer, Laurent</au><au>Capdevielle, Delphine</au><au>Chereau, Isabelle</au><au>Dassing, Romane</au><au>Dorey, Jean-Michel</au><au>Dubertret, Caroline</au><au>Leignier, Sylvain</au><au>Llorca, Pierre-Michel</au><au>Misdrahi, David</au><au>Passerieux, Christine</au><au>Pignon, Baptiste</au><au>Rey, Romain</au><au>Schorr, Benoît</au><au>Schürhoff, Franck</au><au>Urbach, Mathieu</au><au>Fond, Guillaume</au><au>Mallet, Jasmina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset</atitle><jtitle>Schizophrenia research</jtitle><addtitle>Schizophr Res</addtitle><date>2024-02</date><risdate>2024</risdate><volume>264</volume><spage>105</spage><epage>112</epage><pages>105-112</pages><issn>0920-9964</issn><eissn>1573-2509</eissn><abstract>Childhood Attention-deficit/hyperactivity disorder (C-ADHD) is a neurodevelopmental disorder, associated with an increased risk of subsequent schizophrenia. The objective of the present study was to determine the prevalence of C-ADHD in schizophrenia and the clinical and cognitive characteristics associated with C-ADHD history in schizophrenia. 569 subjects with schizophrenia (74 % men, mean age 30.8) were included in ten expert centers at a national level and tested with a comprehensive battery of clinician-rated, patient-reported scales and cognitive tests. C-ADHD was assessed with the WURS (Wender Utah Rating Scale) self-report questionnaire. Multivariate, correlation, and principal component analyses (PCA) were conducted. Thirty-nine subjects (N = 39, 6.9 %) were classified in the C-ADHD group. Compared to those without C-ADHD, subjects with C-ADHD were more frequently male, had lower education levels, more severe positive clinical symptoms, more subjective cognitive deficits complaints, and lower medication adherence with small to medium effect sizes. Two cognitive components emerged from the PCA, one component including perceptual reasoning and working memory, and another component including visuospatial search and graphomotor speed, cognitive inhibition/flexibility and central executive functioning. Both components were associated with lower performances in the C-ADHD group. C-ADHD is frequent in schizophrenia and associated with more severe positive symptoms and impaired cognitive performances compared to those without C-ADHD. This suggests that the pathophysiological mechanisms contributing to these disorders may lead to the worsening of the cognitive functioning in patients with both disorders. C-ADHD is a relevant clinical marker to discriminate subgroups of schizophrenia with different profiles for a precision-psychiatry approach.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38128341</pmid><doi>10.1016/j.schres.2023.12.010</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5121-8769</orcidid><orcidid>https://orcid.org/0000-0002-7146-8554</orcidid><orcidid>https://orcid.org/0000-0001-5050-1362</orcidid><orcidid>https://orcid.org/0000-0001-7438-8990</orcidid><orcidid>https://orcid.org/0000-0003-1146-3206</orcidid><orcidid>https://orcid.org/0000-0003-4130-1590</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0920-9964
ispartof Schizophrenia research, 2024-02, Vol.264, p.105-112
issn 0920-9964
1573-2509
language eng
recordid cdi_hal_primary_oai_HAL_hal_04512686v1
source Access via ScienceDirect (Elsevier)
subjects ADHD
Attention deficit
Healthcare system research
Life Sciences
Mental health
Neurons and Cognition
Psychiatry
Schizophrenia, psychotic disorders
title Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T22%3A19%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20cognitive%20characteristics%20of%20subjects%20with%20schizophrenia%20and%20childhood%20attention-deficit/hyperactivity%20disorder:%20Results%20from%20the%20multicentric%20FACE-SZ%20cross-sectional%20dataset&rft.jtitle=Schizophrenia%20research&rft.au=Dond%C3%A9,%20Cl%C3%A9ment&rft.date=2024-02&rft.volume=264&rft.spage=105&rft.epage=112&rft.pages=105-112&rft.issn=0920-9964&rft.eissn=1573-2509&rft_id=info:doi/10.1016/j.schres.2023.12.010&rft_dat=%3Cproquest_hal_p%3E2905514823%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2905514823&rft_id=info:pmid/38128341&rft_els_id=S0920996423004486&rfr_iscdi=true